Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia

Leukemia Research

Volumn 33, Issue 2, 2009, Pages 344-347

  Holstein, Sarah A ^a   Stokes, John B ^b   Hohl, Raymond J ^a  

^a Div Hematol Oncol Blood M   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Bcr Abl tyrosine kinase inhibitor; Chronic myelogenous leukemia; Renal failure

Indexed keywords

BCR ABL PROTEIN; DAPTOMYCIN; DASATINIB; FUROSEMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; METHYLPREDNISOLONE; NILOTINIB; PENTETATE TECHNETIUM TC 99M;

ADULT; ANEMIA; ARTICLE; BACTEREMIA; BONE MARROW BIOPSY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRANULOCYTE TRANSFUSION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LABORATORY TEST; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

DRUG RESISTANCE, NEOPLASM; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; KIDNEY FAILURE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RENAL DIALYSIS; THIAZOLES;

EID: 56949104034     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.07.029     Document Type: Article

References (13)

1. Pappas P., Karavasilis V., Briasoulis E., Pavlidis N., and Marselos M. Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study. Cancer Chemother Pharmacol 56 (2005) 358-360
2. Kitiyakara C., and Atichartakarn V. Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571. Nephrol Dial Transplant 17 (2002) 685-687
3. Pou M., Saval N., Vera M., Saurina A., Sole M., Cervantes F., et al. Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia. Leuk Lymphoma 44 (2003) 1239-1241
4. Foringer J.R., Verani R.R., Tjia V.M., Finkel K.W., Samuels J.A., and Guntupalli J.S. Acute renal failure secondary to imatinib mesylate treatment in prostate cancer. Ann Pharmacother 39 (2005) 2136-2138
5. Francois H., Coppo P., Hayman J.P., Fouqueray B., Mougenot B., and Ronco P. Partial Fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss. Am J Kidney Dis 51 (2008) 298-301
6. Buchdunger E., Cioffi C.L., Law N., Stover D., Ohno-Jones S., Druker B.J., et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295 (2000) 139-145
7. Weisberg E., Manley P.W., Breitenstein W., Bruggen J., Cowan-Jacob S.W., Ray A., et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 7 (2005) 129-141
8. Das J., Chen P., Norris D., Padmanabha R., Lin J., Moquin R.V., et al. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J Med Chem 49 (2006) 6819-6832
9. Lassila M., Jandeleit-Dahm K., Seah K.K., Smith C.M., Calkin A.C., Allen T.J., et al. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 16 (2005) 363-373
10. Wang S., Wilkes M.C., Leof E.B., and Hirschberg R. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. Faseb J 19 (2005) 1-11
11. Sadanaga A., Nakashima H., Masutani K., Miyake K., Shimizu S., Igawa T., et al. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice. Arthrit Rheum 52 (2005) 3987-3996
12. Zoja C., Corna D., Rottoli D., Zanchi C., Abbate M., and Remuzzi G. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. Kidney Int 70 (2006) 97-103
13. Yu C.C., Yen T.S., Lowell C.A., and DeFranco A.L. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol 11 (2001) 34-38